The endocannabinoidome-gut microbiome-brain axis as a novel therapeutic target for autism spectrum disorder

CONCLUSION: The eCBome-GM-brain axis is a promising target for ASD treatment, meriting further clinical and preclinical research.

via https://pubmed.ncbi.nlm.nih.gov/40605060/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250717010905&v=2.18.0.post9+e462414